PharmaJet presentation will highlight the results of recent immunization studies using needle-free intradermal (ID) delivery for polio immunization campaigns. Data reinforces how increased coverage, ...

Needle-free Injection System - Stratis(R) - was used to deliver Scancell's iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 trial. -- The Scancell ...

Needle-free drug injection company PharmaJet is close to completing a $5 million fundraising round of financing that would fund the production of 5 million syringes to deliver the polio vaccine.

PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free technology. The Tropis® intradermal (ID) Needle-free Injection System overcomes ...

GOLDEN, Colo., November 04, 2025--(BUSINESS WIRE)--PharmaJet ®, a company that strives to improve the performance and outcomes of injectables with its needle-free injection technology, will present at ...

There were significantly fewer adverse events associated with needle-free Tropis ® intradermal (ID) delivery as compared to needle and syringe (N/S). Tropis ID delivery was preferred over N/S ID ...

PharmaJet, a commercial-stage world leader in needle-free injection systems to improve the performance and outcomes of injectables with its enabling needle-free injection technology, announced that it ...